Aricept Dosage

Links shared publicly online about this topic

High Dosages Of Alzheimer's Drug Aricept Ban, Watchdog Pushes FDA

medicalnewstoday.com — “The FDA is under pressure to ban studied high dosages of Aricept, a drug used to treat moderate or severe cases of Alzheimer's disease (AD) because of its risk of serious adverse effects and its lView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 5:05 pm By:

josephweaver Joe Weaver, RN Nurse

High Dosages Of Alzheimer's Drug Aricept Ban, Watchdog Pushes FDA http://bit.ly/kYUQpT

1 year ago...

Aricept 23mg approved for Alzheimer's disease - MPR

empr.com — “The FDA has approved Eisai's Aricept (donepezil HCl tablets) in a 23mg dosage strenghth for the treatment of moderate-to-severe Alzheimer's disease.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 26, 2010 at 3:06 pm By:

eMPR MPR Medical Publisher

MPR News: Aricept 23mg approved for Alzheimer's disease: The FDA has approved Eisai's Aricept (donepezil HCl table... http://bit.ly/b1hMsu

2 years ago...

Aricept 23mg approved for Alzheimer's disease - ONA

oncologynurseadvisor.com — “The FDA has approved Eisai--™s Aricept (donepezil HCl tablets) in a 23mg dosage strength for the treatment of moderate-to-severe Alzheimer--™s disease.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 26, 2010 at 3:03 pm By:

NYT: Drug Dosage Was Approved Despi

mobile.nytimes.com — “The Alzheimer's drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at mobile.nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 4:31 am By:

Alzheimer's drug Aricept 23 slammed by medical experts - latimes.com

latimes.com — “Aricept 23 mg, a higher-dosage form of donepezil, is no more effective than alternatives. Its march to market is 'perplexing,' 'depressing,' say medical experts.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 2:43 pm By:

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 3:32 pm By:

DrHubaEvaluator George Huba, Ph.D. Psychologist, PhD, and Doctor

NYT: Drug Dosage Was Approved Despite Warning - Aricept 23 was developed by the Japanese pharmaceutical company Eisa... http://t.co/KAZJYoT9

2 months ago...

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 5:44 am By:

Health_CK Catherine K Health Advocate

Drug Dosage Was Approved Despite Warning: The Alzheimer’s drug Aricept 23 was set to lose its patent, but its ma... http://t.co/jE15Ig2q

2 months ago...

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 5:25 am By:

HealthTrendster HealthTrendster Health Executive

Drug Dosage Was Approved Despite Warning - Aricept 23 was developed by the Japanese pharmaceutical company Eisai and... http://t.co/59MH8fp0

2 months ago...

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:05 pm By:

swhitbo Susan Krauss Whitbourne Doctor, Psychologist, and PhD

Chilling tale about Aricept's approval for stronger dose despite high risks and lack of effectiveness. #pharma #psych http://t.co/wUEvIdMi

2 months ago...

Why Adjust The Dosage on A Useless Drug? | GoozNews

gooznews.com — “Professors Lisa Schwartz and Steven Woloshin of the Center for Medicine and the Media at The Dartmouth Institute for Health Policy and Clinical Practice ar...View full resource at gooznews.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 7:54 pm By:

medicallessons elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist

Excellent points here, re: FDA, Aricept for Alzheimer's, ads...MT @bacigalupe: Why Adjust The Dosage on A Useless Drug? http://t.co/WAh42fH2

2 months ago...

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:05 am By:

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 2:47 am By:

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:57 pm By:

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:57 pm By:

Drug Dosage Was Approved Despite Warning - NYTimes.com

nytimes.com — “The Alzheimer’s drug Aricept 23 was set to lose its patent, but its makers received approval for a higher dosage that extended their exclusivity.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:49 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • josephweaver

    Joe Weaver, RN

    Registered Nurse & Author will post medical, mental health and smoking cessation tweet, not intended to diagnose, prevent, or treat illness.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

  • ONAcom

    OncologyNurseAdvisor

    Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390